CLAUDETTE BLAKE: Open Payments
NPI 1841804960 · MOUNTAINSIDE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,063 in 55 payments from 10 companies in 2025. Trend: 2023 $676 · 2024 $1,098 · 2025 $1,063
Food & beverage: $1,063
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $365 |
| Teva Pharmaceuticals USA, Inc. | 4 | $176 |
| Otsuka America Pharmaceutical, Inc. | 8 | $149 |
| Neurocrine BioSciences, Inc. | 7 | $132 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $87 |
| Alkermes, Inc. | 3 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $36 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Bausch Health US, LLC | 1 | $17 |
| Indivior Inc. | 1 | $17 |
Products named: VRAYLAR, UZEDY, REXULTI, INGREZZA, CAPLYTA, ARISTADA, SPRAVATO, Auvelity.
Industry payments across NJ — which companies pay providers there.
